The disagreement began when NuGen filed a lawsuit seeking a ruling of non-infringement of two of KeyGene's US patents related to next-generation sequencing.
KeyGene and its parent firm, KeyGene NV, were named as defendants in a NuGen Technologies suit seeking to invalidate two US patents.
The patent claims strategies for identifying optimal breeding combinations of crop plants or cattle within a breeding population.
The technology allows for genome-wide SNP discovery and genotyping in large populations of organisms in a single experiment.
The company also extended its existing licensing agreement with Genalice, signed in 2013, to improve plant DNA analysis.
The assembly of the agricultural pest Rhizoctonia solani genome was more contiguous and larger than previous short-read assemblies.
The two companies will use KeyGene's technology for the genetic analysis of field and vegetable crops.
The deal allows Floragenex to extend its SBG service offerings to include double digest RAD-Seq in non-commercial and academic research across all species.
The companies began working together in 2012 to validate the read alignment and variant calling technology for use in plant genomics.
NEW YORK (GenomeWeb) – KeyGene today announced it has licensed its sequencing-based genotyping technology to the University of Edinburgh for research purposes.
A genome-wide association study highlights a potential role for hair follicles in acne risk, according to New Scientist.
Newsday reports that breast cancer genetic testing guidelines for are out of date and may miss individuals.
In Cell this week: gene editing-based strategy to screen for immune system regulators, ancient plague patterns, and more.
Publication of He Jiankui's work on gene-edited infants would raise ethical concerns for journals, Wired and others report.